Skip to main content
. 2018 Mar 9;115(10):157–162. doi: 10.3238/arztebl.2018.0157

Table 2. Prognostically favorable subgroups for surgical ?intervention and their survival.

Subgroups Survival
Peritoneal carcinomatosis of a
papillary adenocarcinoma in women
Median
15–42 months
Axillary lymph node metastasis of
adenocarcinoma in women
5 YS 72%
Cervical lymph node metastases of
squamous cell
5 YS 40–60%
Inguinal lymph node metastases 5 YS 37.5%
Mediastinal / retroperitoneal
metastasis along the midline
Insufficient data
Localized, resectable metastases Insufficient data

(modified according to [18, 20]); 5 YS: 5-year survival rate